X4 Pharmaceuticals, Inc Earnings Per Share, Basic in USD/shares from 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to Q3 2025.
  • X4 Pharmaceuticals, Inc Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.69 USD/shares, a 87.4% increase year-over-year.
  • X4 Pharmaceuticals, Inc Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -4 USD/shares, a 1822% decline year-over-year.
  • X4 Pharmaceuticals, Inc annual Earnings Per Share, Basic for 2024 was -0.19 USD/shares, a 66.7% increase from 2023.
  • X4 Pharmaceuticals, Inc annual Earnings Per Share, Basic for 2023 was -0.57 USD/shares, a 62.5% increase from 2022.
  • X4 Pharmaceuticals, Inc annual Earnings Per Share, Basic for 2022 was -1.52 USD/shares, a 61.9% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

X4 Pharmaceuticals, Inc Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$4 -$1 +$4.79 +87.4% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 -$9 -$3 -$17 -126% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 $7.00 $0.04 +$7.81 Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-01
Q4 2024 $0 -$1 $0 -657% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-26
Q3 2024 $0 -$5 -$5 -54700% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 $5.00 $13.60 +$13.90 Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 -$8 -$8 -$8 -4756% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-01
Q4 2023 $0 $0 $0 -217% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-26
Q3 2023 $0 $0 +$0.25 +96.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $0 $0 +$0.27 +45% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $0 $0 +$0.56 +77.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$1 $0.06 Oct 1, 2022 Dec 31, 2022 10-K 2025-03-26
Q3 2022 $0 +$0.50 +65.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$1 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$1 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03

X4 Pharmaceuticals, Inc Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 +$0.38 +66.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-26
2023 -$1 +$0.95 +62.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-26
2022 -$2 +$2.47 +61.9% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-26
2021 -$4 -$1 -29.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 -$3 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.